Tesamorelin 20 mg — Certificate of Analysis — 2/20/2026
| Compound | Tesamorelin |
|---|---|
| Strength / claim | 20 mg |
| Report type | Certificate of Analysis |
| Report ID | 53p4vum |
| Issued | Pending Review |
| Tested | 2/20/2026 |
| Laboratory | Finnrick Analytics |
| Purity | 99.70% |
| Reported content | 20 mg |
No exact-strength live product match; current catalogue contains 2 mg and 5 mg products.
Published for research documentation and batch-reference purposes. Laboratory results are not therapeutic or clinical evidence.